Evome Medical Technologies Executes Non-Binding Letter of Intent to Extend Remaining Simbex Acquisition Debt to June 2025; Increases Sales Targets by 7.5% for Biodex Distribution Contracts; Raises Biodex Product Pricing by 2% for 2024
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 07 2024
0mins
Should l Buy EVMT?
Source: businesswire
Trade with 70% Backtested Accuracy
Analyst Views on EVMT
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Joint Venture Challenges: Sony and Honda's electric vehicle venture, Sony Honda Mobility, faces challenges entering the U.S. market in 2026 due to potential policy changes under President-elect Donald Trump, including the elimination of the $7,500 EV tax credit which could decrease sales by nearly 30%.
Afeela Sedan Features: The Afeela sedan prototype, set to be unveiled at CES 2025, aims to differentiate itself with advanced technology such as 45 cameras and sensors, an entertainment-focused cabin, and software updates akin to smartphones, despite the competitive landscape dominated by Tesla.
See More





